Veradigm | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Alcidion AUD 15.37M 7.78M 2024-12
Ambu A/S DKK 942M 17M 2025-03
Amplifon EUR 138.02M 818M 2025-03
Cardinal Health USD 2.12B 182M 2025-03
Centene USD 5.2B 1.48B 2025-03
Charles River Laboratories USD 340.1M 20.42M 2025-03
Cigna USD 6.61B 144M 2025-03
Convatec Group 660.5M 348.95M 2024-12
CVS Health USD 14.4B 1.5B 2025-03
Diasorin 188M 9.93M 2024-09
Elevance Health 11.94B 215M 2024-12
General Electric USD 3.73B 102M 2025-03
Gulf Medical Proj AED 46.22M 8.48M 2025-03
Humana 3.83B 3.35B 2024-12
IQVIA Holdings USD 1.3B 80M 2025-03
Kora Saude BRL 113.38M 10.6M 2024-12
Laboratory Of America USD 948M 51.7M 2025-03
Maximus USD 338.82M 37.26M 2025-03
McKesson USD 3.38B 126M 2025-03
Med Life RON 595.95M 109.04M 2024-12
Molina Healthcare USD 1.67B 172M 2025-03
Omnicell USD 110.94M 31.99M 2025-03
Oriola-kd EUR 42.6M 4.8M 2024-12
Owens Minor USD 526.01M 53.75M 2025-03
Quest Diagnostics USD 869M 11M 2025-03
Rede D'or Sao Luiz BRL 2.71B 315.36M 2025-03
Siemens Healthineers EUR 2.32B 171M 2025-03
Sonova Holding CHF 1.32B 47.7M 2024-09
UnitedHealth 21.31B 1.72B 2024-12
Veeva Systems USD 539.9M 15.08M 2025-01
Walgreens Boots Alliance USD 6.51B 428M 2025-05
Xerox USD 426M 76M 2025-03



Veradigm Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.